Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Bio-Path Holdings, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 19 | 17 | −2 |
| Shares | 471.5K | 441.9K | −29.6K (−6.3%) |
| Value | $3.31M | $2.94M | −$365.0K (−11.0%) |
New holders (4)
Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 17,744 | $119.0K | 0.00% |
| State Street Corp | 12,133 | $81.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 209 | $1.00K | 0.00% |
| Crewe Advisors LLC | 70 | $0 | 0.00% |
Sold out (6)
Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Renaissance Technologies LLC | 73,800 | $518.0K |
| Sabby Management, LLC | 71,920 | $505.0K |
| Human Investing LLC | 2,000 | $14.0K |
| Captrust Financial Advisors | 250 | $2.00K |
| Bank of Montreal | 10 | $0 |
| Sowell Financial Services LLC | 20 | $0 |